Harish Rana v. Union of India & Ors.

1. Case Title

Case Name: Harish Rana v. Union of India & Ors.

Citation: 2026 INSC 222; arising out of Miscellaneous Application No. 2238 of 2025 in Special Leave Petition (Civil) No. 18225 of 2024.

Court: Supreme Court of India, Extra-Ordinary Appellate Jurisdiction.

Date of Judgment: 11 March 2026.

Bench: Justice J.B. Pardiwala and Justice K.V. Viswanathan (concurring, separate opinions).

2. Background and Facts of the Case

Harish Rana, a 20-year-old engineering student in 2013, suffered a diffuse axonal brain injury after falling from the fourth floor of his paying-guest accommodation. He spent weeks at PGI Chandigarh before being transferred to AIIMS and other hospitals in Delhi, and did not regain consciousness for many months. He was kept alive for the next thirteen years by means of a tracheostomy, a urinary catheter, and Clinically Assisted Nutrition and Hydration (CANH) administered via a PEG tube, with disability certificates recording a permanent vegetative state (PVS) and total permanent impairment.

Harish’s parents moved the Delhi High Court seeking to invoke the passive-euthanasia framework laid down in Common Cause v. Union of India, (2018) 5 SCC 1. In July 2024, the High Court rejected the petition on the ground that, since Harish was breathing spontaneously and was not on a ventilator, he could not be said to be kept alive by “external aid” as the guidelines required. On appeal, the Supreme Court disposed of the case in November 2024 by ordering increased, publicly funded home care, without considering withdrawal of treatment.

As Harish’s condition deteriorated, his parents filed the present Miscellaneous Application seeking constitution of medical boards under Common Cause and a declaration that CANH is itself “medical treatment” capable of withdrawal. Finding his chance of recovery to be almost non-existent, a Primary Medical Board at AIIMS concluded in June 2025 that Harish’s brain damage was permanent and irreversible, and that continued CANH offered no further therapeutic gain.

3. Issues Before the Court

The Court identified four issues:

1. Whether CANH administered via a PEG tube is “medical treatment” under the Common Cause criteria.
2. The meaning of the “best interests of the patient” principle where the patient lacks decision-making capacity and has left no advance directive.
3. Whether it was in Harish Rana’s best interest that his life be artificially prolonged.
4. What process should govern withdrawal of treatment, both for Harish and for similarly situated patients nationwide.

4. Arguments Advanced by the Applicant

Counsel for the applicant grounded the case in the right to die with dignity under Article 21, relying on Common Cause. It was argued that CANH is not analogous to routine oral feeding; it is a technologically assisted, surgically invasive, and clinically monitored process that must be regarded as medical therapy capable of withdrawal, just like mechanical ventilation or dialysis. The applicant urged the Court to reframe the inquiry — not whether death was in the patient’s best interests, but whether any legal or medical purpose was served by extending an existence devoid of consciousness — and noted that the family had been forced into prolonged litigation because no clear procedure existed for patients being cared for at home. Given the unanimous medical and family position, a waiver of the thirty-day reconsideration period was also requested.

5. Arguments Advanced by the Union of India

The Additional Solicitor General adopted a supportive rather than adversarial position, accepting that CANH is treatment capable of withdrawal, and that such withdrawal is not an act of killing but a lawful omission to treat once the treatment has ceased to have therapeutic effect. The Union’s stance rested on the medical boards’ findings of irreversibility and futility; it endorsed the family’s choice and offered palliative-care resources for an “ordered withdrawal.” In effect, the Union’s submissions were less an opposition than a request for judicial guidance on an already partly worked-out roadmap.

6. Relevant Statutory and Constitutional Provisions

Article 21 was the interpretive focal point of the judgment: “life” was understood to mean more than mere biological survival, extending — even in the process of dying — to a life with dignity. The Common Cause guidelines, particularly the operative clauses on Advance Medical Directives, Primary and Secondary Medical Boards, and the role of the Judicial Magistrate First Class, were important in demarcating the procedural stages and identifying which forum — Article 32 or Article 226 — a family may approach. Beyond the Constitution itself, this framework remains largely a product of judicial elaboration; dedicated legislation is still awaited, a gap the Court repeatedly flagged as requiring urgent Parliamentary action.

7. Court’s Analysis and Reasoning

The Court’s reasoning proceeded on two limbs: whether CANH is “treatment,” and how best interests are to be determined for a patient who cannot express a view.

On the first limb, the Bench relied on comparative jurisprudence — the House of Lords’ decision in Airedale NHS Trust v. Bland and the New Jersey Supreme Court’s decision in In re Quinlan. In Bland, Lord Keith held that a court must look at the “whole regime of medical treatment” rather than draw an arbitrary line between nourishment on one side and surgical apparatus on the other. Following this reasoning, the Court concluded that CANH delivered through a PEG tube is as much an instance of technologically mediated intervention as a ventilator or dialysis. The fact that it can be administered at home makes no difference: it remains prescribed and monitored by professionals, and to hold otherwise would deprive doctors of the freedom to judge its ongoing therapeutic worth.

On the second limb, the Court did not frame the question as whether death was in the patient’s best interests — which it held to be an improper framing — but rather, following Lord Goff in Bland, asked whether it was in the patient’s best interests that his life be prolonged by treatment. This inquiry has a medical limb (futility, irreversibility, continued suffering) and a further limb of “substituted judgment” — reconstructing, as best as possible, what the patient himself would likely have wanted. The Court adopted the English “balance sheet” methodology from Re A (Male Sterilisation) to weigh these factors cumulatively.

Applying this framework, the unanimous findings of the medical boards, together with what the family said about Harish’s presumed wishes (he had left no written directive), tipped the balance in favour of withdrawing treatment. Running through the judgment as a recurring undertone — and reinforcing its call for Parliament to legislate urgently — is the Court’s concern that families worn down by prolonged caregiving may be at risk of having best-interest determinations unduly influenced by non-medical or financial factors rather than the patient’s own interests.

8. Final Decision and Directions

The Supreme Court granted the application in full, allowing withdrawal of CANH and all life-sustaining treatment, and waived the thirty-day reconsideration period given the unanimous agreement between the family and both medical boards. AIIMS was directed to admit Harish and put in place a protocol for end-of-life care. Beyond the facts of this case, the Court directed CMOs to maintain standing panels for Secondary Medical Board recommendations within forty-eight hours; directed hospitals to arrange admission for home-bound patients; directed High Courts to guide Judicial Magistrates First Class on handling withdrawal intimations; and gave families recourse under Article 226 where a hospital fails to act. On 14 March 2026, Harish was transferred to AIIMS’s palliative care unit; he died on 24 March 2026, and his family donated his heart valves and corneas.

9. Ratio Decidendi

The binding principle is twofold:

1. CANH delivered through a device such as a PEG tube qualifies as medical treatment, not basic care, and can lawfully be withdrawn in accordance with the Common Cause framework.
2. Where an individual lacks capacity to decide and has left no Advance Medical Directive, withdrawal must proceed on the basis of the patient’s best interests, determined through a balance-sheet approach weighing medical futility and irreversibility against a reconstruction of the patient’s likely wishes through substituted judgment.

10. Obiter Dicta

The Court’s remarks on how legislative inaction may allow financial distress to subtly influence ostensibly medical decisions stand as a warning to future courts. It also expressed disapproval of hospitals treating “discharge against medical advice” as a casual substitute for a formal palliative-care plan — an observation likely to affect hospital practice even though it did not arise as a live issue on the facts.

11. Significance of the Judgment

Harish Rana is the moment at which passive-euthanasia jurisprudence in India moved from constitutional principle to an implementable process. Common Cause supplied the framework; this ruling tested and refined it against a real, prolonged medical crisis. By treating CANH as medical treatment, the Court resolved an ambiguity that had persisted since 2018 and brought Indian law closer to the position in England and the United States. It gives hospitals and physicians a workable best-interest framework, and should shorten the delays that had turned an already difficult process into protracted litigation — particularly for families caring for relatives at home, supported by CMO panels, hospital facilitation, and High Court oversight.

12. Critical Analysis

The strength of the judgment lies in its refusal to let CANH’s classification be reduced to a matter of mere terminology, and in grounding that classification in comparative case law and clinical reality. The best-interest framework, too, is a significant advance on the limited guidance available after Common Cause. That said, the substituted-judgment element continues to rely on family testimony that is inherently difficult to verify and is subject to the same financial pressures the Court itself warns against. The borrowed “balance sheet” model, developed in resource-rich settings, may not transfer easily to India, where access to palliative care and specialist medical boards remains starkly uneven between urban and rural areas. The Court’s candid acknowledgment of these risks is commendable, but it also makes clear that judicial standards remain an imperfect substitute for the legislation the Court itself is calling for.

13. Conclusion

Harish Rana v. Union of India will likely be remembered less for novel constitutional doctrine than for the disciplined implementation of ground already broken in Common Cause. In settling CANH’s status as medical treatment and offering a clear, two-part best-interest standard, the Court gave physicians, hospitals, and families a workable path through an emotionally and legally difficult process. Its candid acknowledgment of legislative silence, paired with concrete directions to CMOs, hospitals, and High Courts, reflects a judgment as concerned with implementation as with doctrine. For one family — and plausibly many more to come — this case marks the point at which India’s right to die with dignity moved from constitutional promise to lived experience.